BIO-11006
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for BIO-11006, covering 2020-05-19 to 2024-11-08. Get the full timeline:
Most recent: Clinical Trial Update: BIO-11006 for Osteosarcoma and Ewing's Sarcoma Lung Metastases [Phase 2]